Physician profile
Ronald E Strobel
NPI 1952360240
$9,236.42
in general payments reported to CMS, 2019-2025
39 companies · $1,178 in 2025
The $1,178 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,513 · 2020: $1,185 · 2021: $1,551 · 2022: $874 · 2023: $1,613 · 2024: $1,323 · 2025: $1,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,085 · Education: $28.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,085.25 |
| Education | $28.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,526.67 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,288.83 | 2019-2024 | Xarelto |
| Amgen INC. | $1,069.24 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals Lp | $873.58 | 2019-2025 | Farxiga, Wainua |
| Medtronic, INC. | $668.39 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan |
| Amarin Pharma, INC. | $533.33 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $404.20 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $377.93 | 2019-2025 | Jardiance |
| Baxter Healthcare | $289.88 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $257.91 | 2019-2021 | |
| Pfizer INC. | $200.37 | 2020-2025 | |
| Medtronic Vascular, INC. | $196.05 | 2020 | |
| Esperion Therapeutics, INC. | $156.72 | 2021-2024 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $149.71 | 2019-2022 | |
| Preventice Services, LLC | $132.33 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $126.32 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $114.84 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $83.25 | 2021-2023 | Lifevest |
| Irhythm Technologies, INC. | $82.26 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Bridgebio Pharma, INC. | $69.87 | 2025 | Attruby |
| Medicomp INC | $65.73 | 2024-2025 | Telepatch Cardiac Monitor |
| Cvrx, INC. | $58.54 | 2024 | Barostim Neo System |
| Abiomed | $57.58 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $56.54 | 2019-2025 | Camzyos |
| Kiniksa Pharmaceuticals, Ltd. | $44.34 | 2023 | Arcalyst |
| Boston Scientific Corporation | $43.92 | 2022-2024 | Zoom Wireless Transmitter |
| Atricure, INC. | $42.76 | 2023 | |
| Lundbeck LLC | $36.69 | 2019-2021 | |
| Lilly USA, LLC | $34.82 | 2024-2025 | Zepbound, Mounjaro |
| Alnylam Pharmaceuticals INC. | $31.71 | 2025 | Amvuttra |
| Impulse Dynamics (USA) INC. | $27.32 | 2022 | |
| Abbott Laboratories | $27.02 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $26.94 | 2025 | Rhythm Express |
| Portola Pharmaceuticals, LLC | $14.48 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.23 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $14.04 | 2024 | |
| Heartflow, INC. | $13.30 | 2023 | Ffrct |
| Ani Pharmaceuticals, INC. | $13.11 | 2024 | Purified Cortrophin Gel |
| Allergan, INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Strobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.